Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Traxion Sab De Cv Ord Shs GRPOF

Grupo Traxion SAB de CV is a Mexico-based company engaged in the transportation sector. The Company provides logistics services within eight business areas: Fright, including intermodal and multimodal services, door-to-door, national and cross-border distribution, among others; Integrated logistics, including logistics management, aerial and maritime services and custom transportation support services; Warehousing, including dedicated storage, shared warehouses, packing and value-added services, such as labeling and products assembly; Logistics systems, including software for logistics management; Passenger transportation, including transportation of personnel and students; Special services, including rental of bus and vans; Moving, including national and international moving services, and Advertising, including custom transportation services during marketing campaigns. The Company operates through a number of group companies.


PINL:GRPOF - Post by User

Post by doubleLson Jan 31, 2019 7:26am
217 Views
Post# 29300346

Clarification of deal closing details

Clarification of deal closing details Quick question for the board - was the reason for the spike in SP yesterday that $9m worth of the closing is in stock, and someone is manipulating the SP in order for less shares being required to = $9m worth? Or do the powers at be not care about an added 20-40% additional dilution occurring and the SP increase was more the result of recent exposure and now better NHP lineup and likely earlier revenue being reported? I also now suspect that upon the closing is when we get 100% confirmation and public acknowledgement of our distribution partner - having a larger NHP product line etc available. Is it a mix of both? I loved the discussion over the ocular products in development and research, definitely aligns to what Guy eluded to with respects to monetizing those in 2019! Guesses for where this goes in the coming days? Also.. where are we getting the $3m cash? The recent Aphria injection? Or more future raises coming? Thanks for thoughts,
<< Previous
Bullboard Posts
Next >>